Home LiteratureArticle Details
PMID: 8855263 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

p53-dependent cell cycle arrest induced by N-acetyl-L-leucinyl-L-leucinyl-L-norleucinal in platelet-derived growth factor-stimulated human fibroblasts.

Dietrich C, Bartsch T, Schanz F, Oesch F, Wieser RJ

Abstract

Proteases are known to play important roles in cell growth control, although the underlying mechanisms are still poorly understood. Here we show that the protease inhibitor N-acetyl-L-leucinyl-L-leucinyl-L-norleucinal induced cell cycle arrest in platelet-derived growth factor-stimulated human fibroblasts at the G1/S boundary of the cell cycle by inhibiting the proteasome. Inhibition of the proteasome resulted in accumulation of the tumor suppressor p53, which was followed by an increase in the amount of the cyclin-dependent kinase-inhibitor p21. As a consequence, both phosphorylation and activity of the cyclin-dependent kinase 2/cyclin E complex were inhibited. We further observed that the retinoblastoma gene product, pRb, remained in the hypophosphorylated state, thus preventing cells from progression into the S-phase. These studies strongly support the hypothesis that the proteasome is a key regulator in the G1-phase of cell cycle progression.

MeSH Terms
Calpain/antagonists & inhibitors Cathepsins/antagonists & inhibitors Cell Cycle/drug effects Cells, Cultured Cysteine Endopeptidases/metabolism Cysteine Proteinase Inhibitors/pharmacology Fibroblasts/cytology Humans Leupeptins/pharmacology Lung/cytology Multienzyme Complexes/metabolism Platelet-Derived Growth Factor/pharmacology Proteasome Endopeptidase Complex Tumor Suppressor Protein p53/physiology
Chemicals
Cysteine Proteinase Inhibitors Leupeptins Multienzyme Complexes Platelet-Derived Growth Factor Tumor Suppressor Protein p53 acetylleucyl-leucyl-norleucinal Cathepsins Calpain Cysteine Endopeptidases Proteasome Endopeptidase Complex
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Dietrich C
Institute of Toxicology, Mainz, Germany.
Bartsch T
Schanz F
Oesch F
Wieser R J
References (33)
33 references, click to expand
  1. In vivo ubiquitination and proteasome-mediated degradation of p53(1).
    Cancer Res. 1996 Jun 1;56(11):2649-54 PMID: 8653711
  2. Both p16 and p21 families of cyclin-dependent kinase (CDK) inhibitors block the phosphorylation of cyclin-dependent kinases by the CDK-activating kinase.
    J Biol Chem. 1995 Aug 4;270(31):18195-7 PMID: 7629134
  3. A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids.
    Anal Biochem. 1984 Apr;138(1):141-3 PMID: 6731838
  4. Involvement of plasma membrane glycoproteins in the contact-dependent inhibition of growth of human fibroblasts.
    Exp Cell Res. 1985 Jun;158(2):493-9 PMID: 3924641
  5. Thiol protease-specific inhibitor E-64 arrests human epidermoid carcinoma A431 cells at mitotic metaphase.
    Proc Natl Acad Sci U S A. 1988 Jan;85(1):146-50 PMID: 3422411
  6. The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element.
    Cell. 1989 Sep 22;58(6):1085-95 PMID: 2673542
  7. Human p53 is phosphorylated by p60-cdc2 and cyclin B-cdc2.
    Proc Natl Acad Sci U S A. 1990 Jun;87(12):4766-70 PMID: 2141171
  8. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53.
    Cell. 1990 Dec 21;63(6):1129-36 PMID: 2175676
  9. Cyclin is degraded by the ubiquitin pathway.
    Nature. 1991 Jan 10;349(6305):132-8 PMID: 1846030
  10. G1/S phosphorylation of the retinoblastoma protein is associated with an altered affinity for the nuclear compartment.
    Cell. 1991 May 3;65(3):381-93 PMID: 2018973
  11. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins.
    Cell. 1992 Sep 18;70(6):993-1006 PMID: 1388095
  12. Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle.
    Science. 1992 Sep 18;257(5077):1689-94 PMID: 1388288
  13. Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15.
    EMBO J. 1992 Nov;11(11):3995-4005 PMID: 1396589
  14. Association of human cyclin E with a periodic G1-S phase protein kinase.
    Science. 1992 Sep 25;257(5078):1958-61 PMID: 1329201
  15. Dipeptide inhibitors of ubiquitin-mediated protein turnover prevent growth factor-induced neurite outgrowth in rat pheochromocytoma PC12 cells.
    Biochem Biophys Res Commun. 1992 Nov 30;189(1):280-8 PMID: 1333189
  16. Effects of thiol protease inhibitors on cell cycle and proliferation of vascular smooth muscle cells in culture.
    Circ Res. 1993 Feb;72(2):413-23 PMID: 8418992
  17. Evidence for the presence of five distinct proteolytic components in the pituitary multicatalytic proteinase complex. Properties of two components cleaving bonds on the carboxyl side of branched chain and small neutral amino acids.
    Biochemistry. 1993 Feb 16;32(6):1563-72 PMID: 8431436
  18. In vivo inhibition of cyclin B degradation and induction of cell-cycle arrest in mammalian cells by the neutral cysteine protease inhibitor N-acetylleucylleucylnorleucinal.
    Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3353-7 PMID: 8386372
  19. Integration of cell cycle control with transcriptional regulation by the retinoblastoma protein.
    Curr Opin Cell Biol. 1993 Apr;5(2):194-200 PMID: 8507491
  20. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
    Cell. 1993 Nov 19;75(4):805-16 PMID: 8242751
  21. WAF1, a potential mediator of p53 tumor suppression.
    Cell. 1993 Nov 19;75(4):817-25 PMID: 8242752
  22. p21 is a universal inhibitor of cyclin kinases.
    Nature. 1993 Dec 16;366(6456):701-4 PMID: 8259214
  23. Accumulation of p53 in a mutant cell line defective in the ubiquitin pathway.
    Mol Cell Biol. 1994 Mar;14(3):1997-2003 PMID: 8114731
  24. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest.
    Cell. 1994 Mar 25;76(6):1013-23 PMID: 8137420
  25. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules.
    Cell. 1994 Sep 9;78(5):761-71 PMID: 8087844
  26. The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B.
    Cell. 1994 Sep 9;78(5):773-85 PMID: 8087845
  27. G1 phase progression: cycling on cue.
    Cell. 1994 Nov 18;79(4):551-5 PMID: 7954821
  28. Inhibition of growth of human TE2 and C-33A cells by the cell-permeant calpain inhibitor benzyloxycarbonyl-Leu-Leu-Tyr diazomethyl ketone.
    Exp Cell Res. 1994 Nov;215(1):164-71 PMID: 7957664
  29. Protein ubiquitination involving an E1-E2-E3 enzyme ubiquitin thioester cascade.
    Nature. 1995 Jan 5;373(6509):81-3 PMID: 7800044
  30. Calpain inhibition: an overview of its therapeutic potential.
    Trends Pharmacol Sci. 1994 Nov;15(11):412-9 PMID: 7855906
  31. Ubiquitin, proteasomes, and the regulation of intracellular protein degradation.
    Curr Opin Cell Biol. 1995 Apr;7(2):215-23 PMID: 7612274
  32. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27.
    Science. 1995 Aug 4;269(5224):682-5 PMID: 7624798
  33. Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
    Nature. 1970 Aug 15;227(5259):680-5 PMID: 5432063
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
1996-10-01
Pages
10815-9
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC38238
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com